Transfection Technology

Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Rep Id : TMRGL1001
  • Published On : Apr 2014
  • No. of Pages : 120
  • Category : Healthcare

 
Chapter 1 Preface 
1.1 Report Description 
1.2 Market Segmentation 
1.3 Research Methodology 
1.4 List of Abbreviations
 
Chapter 2 Executive Summary 
2.1 Market Snapshot: Global Transfection Technology  Market (2012 & 2019) 
      2.1.1 Global Transfection Technology Market, by Methods, 2012 (USD Million) 
2.2 Comparative Analysis: Global Transfection Technology Market, By Geography, 2012 and 2019 (Value %)
 
Chapter 3 Market Overview 
3.1 Market Definition and Overview 
3.2 Market Dynamics 
      3.2.1 Drivers 
               3.2.1.1 Protein production promotes the use of transfection technology methods 
               3.2.1.2 Emerging biopharmaceutical markets in Asia boost transfection needs 
      3.2.2 Restraints 
               3.2.2.1 High cost prevents sufficient market expansion 
      3.2.3 Opportunities 
               3.2.3.1 Transfection technologies for stem cell research 
3.3 Porters Five Force Analysis for the Global Transfection Technology Market 
      3.3.1 Bargaining Power of Suppliers 
      3.3.2 Bargaining Power of Buyers 
      3.3.3 Threat of Substitutes 
      3.3.4 Threat of New Entrants 
      3.3.5 Competitive Rivalry 
3.4 Market Attractiveness Analysis 
3.5 Competitive Landscape 
      3.5.1 Market Share Analysis by Key Players, 2012 (Value %)
 
Chapter 4 Global Transfection Technology Market, by Methods 
4.1 Overview 
      4.1.1 Global Transfection Technology Market Revenue, by Methods, 2011 – 2019 (USD Million) 
4.2 Reagent-based Methods 
      4.2.1 Global Reagent Based Market Revenue, by Types, 2011 – 2019 (USD Million) 
      4.2.2 Lipid Mediated Transfection (Lipofection) 
               4.2.2.1 Global Lipid Mediated Transfection Market Revenue, 2011 – 2019 (USD Million) 
      4.2.3 Calcium Phosphate 
               4.2.3.1 Global Calcium Phosphate Transfection Market Revenue, 2011 – 2019 (USD Million) 
      4.2.4 Cationic Polymers 
               4.2.4.1 Global Cationic Polymer Market Revenue, 2011 – 2019 (USD Million) 
      4.2.5 DEAE dextran 
               4.2.5.1 Global DEAE-dextran Market Revenue, 2011 – 2019 (USD Million) 
      4.2.6 Activated Dendrimers 
               4.2.6.1 Global Activated Dendrimers Market Revenue, 2011 – 2019 (USD Million) 
      4.2.7 Magnetic Beads (Magnet-mediated transfection) 
               4.2.7.1 Global Magnetic Beads Transfection Market Revenue, 2011 – 2019 (USD Million) 
4.3 Instrument-based Methods 
      4.3.1 Global Instrument Based Method Revenue, by Types, 2011 – 2019 (USD Million) 
      4.3.2 Electroporation 
               4.3.2.1 Global Electroporation Market Revenue, 2011 – 2019 (USD Million) 
      4.3.3 Biolistic Technology 
               4.3.3.1 Global Biolistic Technology Market Revenue, 2011 – 2019 (USD Million) 
      4.3.4 Microinjection 
               4.3.4.1 Global Microinjection Market Revenue, 2011 – 2019 (USD Million) 
      4.3.5 Laserfection 
               4.3.5.1 Global Biolistic Technology Market Revenue, 2011 – 2019 (USD Million) 
4.4 Virus-based Methods 
      4.4.1 Global Virus Based Method Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 5 Global Transfection Technology Market, By Application 
5.1 Overview 
      5.1.1 Global Transfection Technology Market Revenue, by Applications, 2011 – 2019 (USD Million) 
5.2 Bio-medical Research 
      5.2.1 Global Bio-medical Research Market Revenue, by Types, 2011 – 2019 (USD Million) 
      5.2.2 Transgenic Models 
               5.2.2.1 Global Transgenic Model Market Revenue, 2011 – 2019 (USD Million) 
      5.2.3 Cancer Research 
               5.2.3.1 Global Cancer Research Market Revenue, 2011 – 2019 (USD Million) 
      5.2.4 Gene and Protein Expression Studies 
               5.2.4.1 Global Gene and Protein Expression Studies Market Revenue, 2011 – 2019 (USD Million) 
      5.2.5 Cell Based Microarray for Drug Discovery and Development 
               5.2.5.1 Global Cell Based Microarray for Drug Discovery and Development Market Revenue, 2011 – 2019 (USD Million) 
5.3 Therapeutic Delivery 
      5.3.1 Global Therapeutics Delivery Market Revenue, by Types, 2011 – 2019 (USD Million) 
      5.3.2 Biotherapeutics 
               5.3.2.1 Global Biotherapeutics Market Revenue, 2011 – 2019 (USD Million) 
      5.3.3 Electro-chemotherapy and Electro-immunotherapy 
               5.3.3.1 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 – 2019 (USD Million) 
5.4 Protein Production 
      5.4.1 Global Protein Production Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 6 Global Transfection Technology Market, by Geography 
6.1 Overview 
      6.1.1 Global Transfection Technology Market Revenue, by Geography, 2011 – 2019 (USD Million) 
6.2 North America 
      6.2.1 North America Transfection Technology Market Revenue, 2011 – 2019 (USD Million) 
6.3 Europe 
      6.3.1 Europe Transfection Technology Market Revenue, 2011 – 2019 (USD Million) 
6.4 Asia-Pacific 
      6.4.1 Asia-Pacific Transfection Technology Market Revenue, 2011 – 2019 (USD Million) 
6.5 Rest of the World (RoW) 
      6.5.1 RoW Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 7 Recommendations 
7.1 Market Strategy for Success 
      7.1.1 Develop new technologies and product improvement 
      7.1.2 Enhance product portfolio for stem cell research transfection 
7.2 Barriers and Future Assumptions 
      7.2.1 High cost is a barrier for sufficient market expansion
 
Chapter 8 Company Profiles 
8.1 Bio-Rad Laboratories, Inc. 
      8.1.1 Company Overview 
      8.1.2 Financial Overview 
      8.1.3 Product Portfolio 
      8.1.4 Business Strategies 
      8.1.5 Recent Developments 
8.2 Harvard Bioscience, Inc. 
      8.2.1 Company Overview 
      8.2.2 Financial Overview 
      8.2.3 Product Portfolio 
      8.2.4 Business Strategies 
      8.2.5 Recent Developments 
8.3 Life Technologies Corporation 
      8.3.1 Company Overview 
      8.3.2 Financial Overview 
      8.3.3 Product Portfolio 
      8.3.4 Business Strategies 
      8.3.5 Recent Developments 
8.4 Lonza Group Ltd. 
      8.4.1 Company Overview 
      8.4.2 Financial Overview 
      8.4.3 Product Portfolio 
      8.4.4 Business Strategies 
      8.4.5 Recent Developments 
8.5 Merck KGaA 
      8.5.1 Company Overview 
      8.5.2 Financial Overview 
      8.5.3 Product Portfolio 
      8.5.4 Business Strategies 
      8.5.5 Recent Developments 
8.6 Mirus Bio LLC 
      8.6.1 Company Overview 
      8.6.2 Financial Overview 
      8.6.3 Product Portfolio 
      8.6.4 Business Strategies 
      8.6.5 Recent Development 
8.7 Polyplus-transfection S.A. 
      8.7.1 Company Overview 
      8.7.2 Financial Overview 
      8.7.3 Product Portfolio 
      8.7.4 Business Strategies 
      8.7.5 Recent Developments 
8.8 Promega Corporation 
      8.8.1 Company Overview 
      8.8.2 Financial Overview 
      8.8.3 Product Portfolio 
      8.8.4 Business Strategies 
      8.8.5 Strategic Alliance 
      8.8.6 Recent Developments 
8.9 QIAGEN 
      8.9.1 Company Overview 
      8.9.2 Financial Overview 
      8.9.3 Product Portfolio 
      8.9.4 Business Strategies 
      8.9.5 Recent Developments 
8.10 Roche Holding AG 
      8.10.1 Company Overview 
      8.10.2 Financial Overview 
      8.10.3 Product Portfolio 
      8.10.4 Business Strategies 
      8.10.5 Recent Development 
8.11 Sigma-Aldrich Corporation 
      8.11.1 Company Overview 
      8.11.2 Financial Overview 
      8.11.3 Product Portfolio 
      8.11.4 Business Strategies 
      8.11.5 Recent Developments 
8.12 SignaGen Laboratories 
      8.12.1 Company Overview 
      8.12.2 Financial Overview 
      8.12.3 Product Portfolio 
      8.12.4 Recent Developments 
8.13 Thermo Fisher Scientific, Inc. 
      8.13.1 Company Overview 
      8.13.2 Financial Overview 
      8.13.3 Product Portfolio 
      8.13.4 Business Strategies 
      8.13.5 Recent Developments

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Transfection Technology Market (2012 & 2019)
TABLE 3 Global Transfection Technology Market Revenue, by Methods, 2011 – 2019 (USD Million)
TABLE 4 Global Reagent Based Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 5 Global Instrument Based Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Transfection Technology Market Revenue, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Global Bio-medical Research Market Revenue, by Types, 2011 – 2019(USD)
TABLE 8 Drug Delivery Methods with their Carriers/Factors
TABLE 9 Global Therapeutics Delivery Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 10 Global Transfection Technology Market Revenue, by Geography, 2011 – 2019 (USD Million)

 

List of Figures 
 
FIG. 1 Transfection Technology: Market Segmentation
FIG. 2 Global Transfection Technology Market, by Methods, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Transfection Technology Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Transfection Technology Market
FIG. 5 Market Attractiveness Analysis: Global Transfection Technology Market, by Geography
FIG. 6 Market Share Analysis: Transfection Technology Market, 2012 (Value %)
FIG. 7 Global Lipid Mediated Transfection Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Calcium Phosphate Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Cationic Polymer Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global DEAE-dextran Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Activated Dendrimers Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Magnetic Beads Transfection Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Magnetic Beads Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global Biolistic Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global Microinjection Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Biolistic Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Global Virus Based Method Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Global Transgenic Model Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Global Cancer Research Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Global Gene and Protein Expression Studies Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 Global Cell Based Microarray for Drug Discovery and Development Market Revenue, 2011 – 2019 (USD Million)
FIG. 22 Global Biotherapeutics Market Revenue, 2011 – 2019 (USD Million)
FIG. 23 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 – 2019 (USD Million)
FIG. 25 North America Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 26 Europe Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 27 Asia-Pacific Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 28 RoW Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 29 Annual Sales: Bio-Rad Laboratories, Inc., Life Science Segment, 2010 – 2012 (USD Million)
FIG. 30 Annual Sales: Harvard Bioscience, Inc., 2010 - 2012 (USD Million)
FIG. 31 Annual Sales: Life Technologies Corporation, 2010 – 2012 (USD Million)
FIG. 32 Annual Sales: Lonza Group Ltd., Bioscience Segment , 2010 – 2012 (USD Million)
FIG. 33 Annual Sales: Merck KGaA, Merck Millipore , 2010 – 2012 (USD Million)
FIG. 34 Annual Sales: QIAGEN, 2010 – 2012 (USD Million)
FIG. 35 Annual Sales: Roche Holding AG, 2010 – 2012 (USD Million)
FIG. 36 Annual Sales: Sigma-Aldrich Corporation, 2010 – 2012 (USD Million)
FIG. 37 Annual Sales: Thermo Fisher Scientific, 2010– 2012 (USD Million)

.